TLR3 and neoplasm: Toll-like receptor 3 (TLR3) was shown to play a dual role in ovarian cancer by eliminating tumor cells via upregulation of interferons and activation of natural killer cells and also by promoting cancer development (Husseinzadeh and Davenport, 2014).